PPARG and Hepatic fibrosis: PA treatment also alters the miRNA expression profiles in hepatocyte-derived exosomes, which promotes HSCs activation by targeting PPAR-γ expression or Phosphatase and Tensin homolog (PTEN)-induced Kinase 1 (PINK1), thereby accelerating liver fibrosis progression (103–105).